McKesson Corporation Reports Fiscal 2025 Second Quarter Results and Raises Full Year Adjusted EPS Guidance
McKesson Corporation (NYSE: MCK) has released its fiscal 2025 second quarter financial results. Results can be accessed on ...
McKesson Corporation Reports Strong Q2 Earnings Growth
McKesson Corporation ( (MCK) ) has released its Q2 earnings. Here is a breakdown of the information McKesson Corporation presented to its ...
Is McKesson Corporation (MCK) the Best Pharma Stock to Buy Right Now?
We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...
kalkinemedia10h
Baird Sees McKesson Stock Poised for Upside, Driven by US Pharma...
Highlights:,Baird upgraded McKesson Corporation’s stock from Neutral to Outperform, raising its price target to $688 from $531.,McKesson's strong performance in the U.S. Pharmaceutical Distribution ...
Chicago Partners Investment Group LLC Buys 99 Shares of McKesson Co. (NYSE:MCK)
Chicago Partners Investment Group LLC increased its stake in shares of McKesson Co. (NYSE:MCK – Free Report) by 17.0% during ...
Nasdaq3d
Should You Buy, Sell or Hold McKesson Before Q2 Earnings?
McKesson Corporation MCK is scheduled to report second-quarter fiscal 2025 results on Nov. 6, after market close. The company delivered an earnings surprise of 10.06% in the last reported quarter.